Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valacyclovir vs Acyclovir for HSV Suppression in HIV Patients
NCT00002084Phase 3Completed
- Sponsor
- GSK
- Modality
- Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of valaciclovir in herpes simplex (HSV), sponsored by GSK. Status: completed.
02
Drugs
valaciclovir
03
Conditions
herpes simplex (HSV)
Beyond the preview
Go deeper on NCT00002084.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002084.